Melanoma is the most deadly form of skin cancer, estimated by the National Cancer Institute to afflict more than 70,000 people in the United States annually and the incidence rate continues to rise. In a study published online in Genome Research, resea…
More than half of young adults(18-29) interviewed, and 65% of whites, reported at least one sunburn in the last 12 months. The CDC along with the National Cancer Institute analyzed data from The National Health Interview Survey (NHIS), which is an ann…
A study published in Proceedings of the National Academy of Sciences (PNAS), reveals that elevated expression of a gene in the deadly skin cancer melanoma can raise the mortality risk from the tumor, making it a potentially new target for treating mela…
Malignant melanoma cases are on the rise in the UK, with about 10,000 individuals diagnosed each year. This specific type of cancer claims 2,300 deaths annually and disproportionately affects young people. In the UK, malignant melanoma is now the secon…
Malignant Melanoma is known to be highly aggressive, spreading rapidly to other parts of the body if left untreated. It’s extremely rare, however, for it to be able to pass to an unborn fetus. This is what appears to have happened in the case of Briana…
Basal cell carcinoma is a form of skin cancer caused by regular sun exposure, or other ultraviolet radiation, which starts in the top layer of the skin (epidermis), is usually painless and grows slowly. The U.S. Food and Drug Administration just appro…
A study published in the journal Pediatrics shows that most pre-adolescent children do not regularly use sunscreen, and worse, many suffer from sunburn at some point during their childhood. Figures show that people having suffered a major sunburn incid…
A collaboration between a cancer biologist from the University of Milano and 2 physicists has shown that cell senescence occurs spontaneously in melanoma cells, but does not stop their growth Since cancer cells grow indefinitely, it is commonly believe…
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf®) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer. Now, researchers at UCLA’s Jonsson Comprehensive Cancer …
Based on the knowledge that cancer cells grow indefinitely, the general belief is that senescence could act as a barrier against tumor growth and has the potential of being used as a cancer treatment…
